Inogen Inc

25.89+0.5300+2.09%Vol 156.60K1Y Perf -61.03%
May 17th, 2022 16:00 DELAYED
BID18.00 ASK35.09
Open25.70 Previous Close25.36
Pre-Market- After-Market25.89
 - -  - -%
Target Price
36.33 
Analyst Rating
Moderate Buy 2.40
Potential %
40.32 
Finscreener Ranking
★★★★     52.56
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★★+     61.36
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★     46.32
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
5.65 
Earnings Rating
Strong Buy
Market Cap591.20M 
Earnings Date
5th May 2022
Alpha-0.02 Standard Deviation0.17
Beta1.01 

Today's Price Range

25.5825.95

52W Range

22.5182.35

5 Year PE Ratio Range

-108.40302.90

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
13.16%
1 Month
-5.99%
3 Months
-11.03%
6 Months
-23.88%
1 Year
-61.03%
3 Years
-63.74%
5 Years
-68.31%
10 Years
-

TickerPriceChg.Chg.%
INGN25.890.53002.09
AAPL149.243.70002.54
GOOG2 334.0338.18001.66
MSFT266.825.32002.03
XOM92.111.16001.28
WFC43.711.50003.55
JNJ178.820.74000.42
FB202.622.58001.29
GE76.401.77002.37
JPM122.183.92003.31
Financial StrengthValueIndustryS&P 500US Markets
4.30
5.30
0.06
0.07
-
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
48.80
-0.60
5.70
3.80
-5.76
RevenueValueIndustryS&P 500US Markets
351.46M
15.39
-1.66
8.45
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.48-0.3820.83
Q04 2021-0.74-1.01-36.49
Q03 2021-0.290.53282.76
Q02 2021-0.130.22269.23
Q01 2021-0.28-0.0389.29
Q04 2020-0.28-0.2317.86
Q03 2020-0.02-0.08-300.00
Q02 2020-0.080.12250.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.390.00-
9/2022 QR-0.31-106.67Negative
12/2022 FY-1.63-328.95Negative
12/2023 FY-0.42-950.00Negative
Next Report Date-
Estimated EPS Next Report-0.47
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume156.60K
Shares Outstanding22.84K
Shares Float10.56M
Trades Count3.47K
Dollar Volume4.04M
Avg. Volume187.93K
Avg. Weekly Volume188.88K
Avg. Monthly Volume200.06K
Avg. Quarterly Volume174.83K

Inogen Inc (NASDAQ: INGN) stock closed at 25.89 per share at the end of the most recent trading day (a 2.09% change compared to the prior day closing price) with a volume of 156.60K shares and market capitalization of 591.20M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 938 people. Inogen Inc CEO is Scott Wilkinson.

The one-year performance of Inogen Inc stock is -61.03%, while year-to-date (YTD) performance is -23.85%. INGN stock has a five-year performance of -68.31%. Its 52-week range is between 22.51 and 82.35, which gives INGN stock a 52-week price range ratio of 5.65%

Inogen Inc currently has a PE ratio of -28.70, a price-to-book (PB) ratio of 1.61, a price-to-sale (PS) ratio of 1.65, a price to cashflow ratio of 214.00, a PEG ratio of 2.32, a ROA of -4.29%, a ROC of -5.24% and a ROE of -5.70%. The company’s profit margin is -5.76%, its EBITDA margin is 5.70%, and its revenue ttm is $351.46 Million , which makes it $15.39 revenue per share.

Of the last four earnings reports from Inogen Inc, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.47 for the next earnings report. Inogen Inc’s next earnings report date is -.

The consensus rating of Wall Street analysts for Inogen Inc is Moderate Buy (2.4), with a target price of $36.33, which is +40.32% compared to the current price. The earnings rating for Inogen Inc stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Inogen Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Inogen Inc has a Neutral technical analysis rating based on Technical Indicators (ADX : 13.41, ATR14 : 1.37, CCI20 : 19.56, Chaikin Money Flow : -0.04, MACD : -1.33, Money Flow Index : 46.59, ROC : 2.41, RSI : 46.61, STOCH (14,3) : 82.84, STOCH RSI : 1.00, UO : 49.41, Williams %R : -17.16), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Inogen Inc in the last 12-months were: Alison Bauerlein (Option Excercise at a value of $742 435), Alison Bauerlein (Sold 19 264 shares of value $1 493 703 ), Bart Sanford (Option Excercise at a value of $0), Benjamin M. Anderson-Ray (Sold 4 516 shares of value $156 619 ), Brenton Taylor (Option Excercise at a value of $316 570), Brenton Taylor (Sold 7 942 shares of value $595 808 ), Loren L. Mcfarland (Option Excercise at a value of $17 435), Nabil Shabshab (Option Excercise at a value of $0), Raymond O. Huggenberger (Option Excercise at a value of $716 613), Raymond O. Huggenberger (Sold 24 681 shares of value $1 522 417 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Buy
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Hold
3 (60.00 %)
3 (60.00 %)
3 (60.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.40
Moderate Buy
2.40
Moderate Buy
2.40

Inogen Inc

Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.

CEO: Scott Wilkinson

Telephone: +1 805 562-0500

Address: 326 Bollay Drive, Goleta 93117, CA, US

Number of employees: 938

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

49%51%

TipRanks News for INGN

Tue, 11 Jan 2022 15:24 GMT Inogen (INGN) Receives a Hold from Leerink Partners

- TipRanks. All rights reserved.

News

Stocktwits